Clinical Trial Update: A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating Orforglipron (LY3502970) in adults with obesity or overweight has completed; the update likely reports safety, tolerability and pharmac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Orforglipron (orforglipron)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight | Phase 1 | Status: COMPLETED